Pupillometry Guided Remifentanil Administration and Total Opioid Consumption During Propofol - Remifentanil TCI
NCT ID: NCT02576600
Last Updated: 2015-10-19
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
NA
65 participants
INTERVENTIONAL
2010-10-31
2013-04-30
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Pupillary Response to Incremental Tetanic Stimulations Under Propofol-remifentanil TCI
NCT04465773
Influence of Depth of Anesthesia on Pupillary Reactivity to a Standardized Stimulus
NCT02595476
Minto and Eleveld Remifentanil Target Controlled Infusion (TCI) Models: a Clinical Comparison
NCT07259291
Target-controlled Infusion of Propofol and Remifentanil for Postoperative Sedation Guided by the Bispectral Index
NCT00393003
Comparison of Different Propofol Formulations With or Without Remifentanil
NCT01592162
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
TREATMENT
SINGLE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
PUPILLO
Videopupillometer Algiscan peroperative remifentanil target concentration adapted every five minutes to pupillary diameter in patients under propofol and remifentanil TCI
Videopupillometer Algiscan
pupillary diameter measurement every five minutes per-operatively
Propofol
TCI
Remifentanil
TCI
STANDARD
peroperative remifentanil target concentration as standard practice in patients under propofol and remifentanil TCI
Standard practice
remifentanil administration left to the discretion of the anesthesiologist in charge according to standard practice
Propofol
TCI
Remifentanil
TCI
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Videopupillometer Algiscan
pupillary diameter measurement every five minutes per-operatively
Standard practice
remifentanil administration left to the discretion of the anesthesiologist in charge according to standard practice
Propofol
TCI
Remifentanil
TCI
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Elective gynecological surgery
* No ophtalmologic or neurologic disease
* No chronic analgesic medication
* Expected length of surgery 60 minutes minimum
Exclusion Criteria
* chronic analgesic medication
18 Years
60 Years
FEMALE
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Pr Isabelle CONSTANT
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Pr Isabelle CONSTANT
Professor Isabelle Constant
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Isabelle Constant, MD-PHD
Role: STUDY_DIRECTOR
Hôpital Armand Trousseau
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Departement d'anesthesie Hopital Armand Trousseau
Paris, , France
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
Anesthesie Trousseau 001
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.